The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 13, 2019

Filed:

May. 04, 2018
Applicant:

Hoffmann-la Roche Inc., Little Falls, NJ (US);

Inventors:

Delphine Gaufreteau, Basel, CH;

Hans Hilpert, Basel, CH;

Roland Humm, Basel, CH;

Sabine Kolczewski, Basel, CH;

Thorsten Muser, Basel, CH;

Jean-Marc Plancher, Basel, CH;

Theodor Stoll, Basel, CH;

Assignee:

Hoffmann-La Roche Inc., Little Falls, NJ (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 409/14 (2006.01); C07D 401/14 (2006.01); A61K 31/404 (2006.01); A61K 31/44 (2006.01); A61K 31/506 (2006.01); C07D 403/14 (2006.01); A61P 25/36 (2006.01); A61P 25/28 (2006.01); A61P 25/22 (2006.01); A61P 25/32 (2006.01); A61P 25/18 (2006.01); A61P 25/24 (2006.01); A61P 25/08 (2006.01); A61P 25/16 (2006.01); C07D 403/04 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
C07D 409/14 (2013.01); A61K 31/404 (2013.01); A61K 31/44 (2013.01); A61K 31/506 (2013.01); A61P 25/08 (2018.01); A61P 25/16 (2018.01); A61P 25/18 (2018.01); A61P 25/22 (2018.01); A61P 25/24 (2018.01); A61P 25/28 (2018.01); A61P 25/32 (2018.01); A61P 25/36 (2018.01); C07D 401/14 (2013.01); C07D 403/04 (2013.01); C07D 403/14 (2013.01); A61K 45/06 (2013.01); A61K 2300/00 (2013.01);
Abstract

The present invention is concerned with indolin-2-one derivatives of general formula The compounds may be used in the treatment of CNS diseases related to positive (psychosis) and negative symptoms of schizophrenia, substance abuse, alcohol and drug addiction, obsessive-compulsive disorders, cognitive impairment, bipolar disorders, mood disorders, major depression, treatment resistant depression, anxiety disorders, Alzheimer's disease, autism, Parkinson's disease, chronic pain, borderline personality disorder, neurodegenerative disease, sleep disturbances, chronic fatigue syndrome, stiffness, inflammatory disease, asthma, Huntington's disease, ADHD, amyotrophic lateral sclerosis, effects in arthritis, autoimmune disease, viral and fungal infections, cardiovascular diseases, ophthalmology and inflammatory retinal diseases and balance problems, epilepsy and neurodevelopmental disorders with co-morbid epilepsy.


Find Patent Forward Citations

Loading…